- Exchange: Munich
- Sector: Consumer, Non-cyclical
- Industry: Biotechnology
- Sub-Industry: Medical-Biomedical/Gene
Snapshot for Bachem Holding AG (BHM)
| Open: | 31.350 | Day's Range: | 31.041 - 31.350 | Volume: | 0 |
|---|---|---|---|---|---|
| Previous Close: | 31.320 | 52wk Range: | 26.173 - 32.345 | 1-Yr Rtn: | +6.19% |
Key Statistics for BHM
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(12/2013) | 25.1750 |
| Relative P/E vs. DAX | - |
| Earnings Per Share (CHF) (ttm) | - |
| Est. EPS (CHF) (12/2013) | 1.5350 |
| Est. PEG Ratio | 1.0533 |
| Market Cap (M EUR) | 0.00 |
| Shares Outstanding (M) | 0.00 |
| 30 Day Average Volume | 35 |
| Price/Book (mrq) | - |
| Price/Sale (ttm) | - |
| Dividend Indicated Gross Yield | 3.91% |
| Cash Dividend (CHF) | 1.5000 |
| Last Dividend | 04/26/2013 |
| 5 Year Dividend Growth | -8.05% |
| Next Earnings Announcement | 08/23/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for BHM
Company Profile & Key Executives for BHM
Bachem Holding AG manufactures ingredients for pharmaceuticals, generic drugs, and research supplies. The Company produces peptides and amino-acids for medications and laboratory research, and prescription medicines that are no longer patent protected. Bachem sells its products to universities, and pharmaceutical and biotechnology companies.
| Rolf NyfelerChief Executive Officer | Stephan SchindlerChief Financial Officer |
| Daniel ErneChief Technology Officer | Lester MillsChief Marketing Officer |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
BHM News
-
Industry News
Advertisement
- 1
- 2
- 3
- 4
- 5
Advertisement
Sponsored Links
Advertisements
Rate this Page